X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

CRISPR And CRISPR-associated (Cas) Genes Companies

This report lists the top CRISPR And CRISPR-associated (Cas) Genes companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the CRISPR And CRISPR-associated (Cas) Genes industry.

CRISPR And CRISPR-associated (Cas) Genes Top Companies

  1. OriGene Technologies, Inc.

  2. Thermo Fisher Scientific

  3. Takara Bio Inc

  4. Addgene

  5. PerkinElmer Inc. (Horizon Discovery Ltd.)

*Disclaimer: Top companies sorted in no particular order

 CRISPR And CRISPR-associated (Cas) Genes Market Major Players

CRISPR And CRISPR-associated (Cas) Genes Market Concentration

CRISPR And CRISPR-associated (Cas) Genes Market Concentration

CRISPR And CRISPR-associated (Cas) Genes Company List

                            • OriGene Technologies, Inc.

                            • Thermo Fisher Scientific

                            • Takara Bio Inc

                            • PerkinElmer Inc. (Horizon Discovery Ltd.)

                            • Addgene

                            • Merck KGaA

                            • Caribou Biosciences, Inc.

                            • CRISPR THERAPEUTICS

                            • Editas Medicine

                            • Mirus Bio LLC

                            • Intellia Therpeutics

                            • Sangamo Therapeutics

                            • Inscripta, Inc.


                        Specific to CRISPR And CRISPR-associated (Cas) Genes Market
                        Need More Details On Market Players And Competitors?
                        Download Sample

                        CRISPR and CRISPR-associated (Cas) Genes Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)